These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17592075)

  • 1. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).
    Krankenberg H; Schlüter M; Steinkamp HJ; Bürgelin K; Scheinert D; Schulte KL; Minar E; Peeters P; Bosiers M; Tepe G; Reimers B; Mahler F; Tübler T; Zeller T
    Circulation; 2007 Jul; 116(3):285-92. PubMed ID: 17592075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT).
    Zeller T; Tiefenbacher C; Steinkamp HJ; Langhoff R; Wittenberg G; Schlüter M; Buergelin K; Rastan A; Krumsdorf U; Sixt S; Schulte CL; Tübler T; Krankenberg H
    J Endovasc Ther; 2008 Aug; 15(4):390-8. PubMed ID: 18729564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
    Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.
    Schillinger M; Sabeti S; Loewe C; Dick P; Amighi J; Mlekusch W; Schlager O; Cejna M; Lammer J; Minar E
    N Engl J Med; 2006 May; 354(18):1879-88. PubMed ID: 16672699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.
    Krankenberg H; Tübler T; Ingwersen M; Schlüter M; Scheinert D; Blessing E; Sixt S; Kieback A; Beschorner U; Zeller T
    Circulation; 2015 Dec; 132(23):2230-6. PubMed ID: 26446728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures.
    Schlager O; Dick P; Sabeti S; Amighi J; Mlekusch W; Minar E; Schillinger M
    J Endovasc Ther; 2005 Dec; 12(6):676-84. PubMed ID: 16363897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Beschorner U; Noory E; Neumann FJ; Zeller T
    J Endovasc Ther; 2015 Feb; 22(1):22-7. PubMed ID: 25775675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study.
    Chalmers N; Walker PT; Belli AM; Thorpe AP; Sidhu PS; Robinson G; van Ransbeeck M; Fearn SA
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):353-61. PubMed ID: 23070104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
    J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.
    Duda SH; Bosiers M; Lammer J; Scheinert D; Zeller T; Oliva V; Tielbeek A; Anderson J; Wiesinger B; Tepe G; Lansky A; Jaff MR; Mudde C; Tielemans H; Beregi JP
    J Endovasc Ther; 2006 Dec; 13(6):701-10. PubMed ID: 17154704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
    Kasapis C; Henke PK; Chetcuti SJ; Koenig GC; Rectenwald JE; Krishnamurthy VN; Grossman PM; Gurm HS
    Eur Heart J; 2009 Jan; 30(1):44-55. PubMed ID: 19028778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.
    Saxon RR; Dake MD; Volgelzang RL; Katzen BT; Becker GJ
    J Vasc Interv Radiol; 2008 Jun; 19(6):823-32. PubMed ID: 18503895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
    Kudo T; Chandra FA; Ahn SS
    J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
    Krankenberg H; Tübler T; Sixt S; Fischer M; Schmiedel R; Schulte KL; Balzer JO; Kieback A; Fiehn E; Wittenberg G; Ali T; Tiefenbacher C; Jahnke T; Steinkamp HJ; Wegscheider K; Treszl A; Ingwersen M; Zeller T
    J Endovasc Ther; 2014 Aug; 21(4):463-71. PubMed ID: 25101571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioplasty versus bare metal stenting for superficial femoral artery lesions.
    Chowdhury MM; McLain AD; Twine CP
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.
    Schillinger M; Sabeti S; Dick P; Amighi J; Mlekusch W; Schlager O; Loewe C; Cejna M; Lammer J; Minar E
    Circulation; 2007 May; 115(21):2745-9. PubMed ID: 17502568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.